Format

Send to

Choose Destination
J Mol Med (Berl). 2017 Jul;95(7):779-787. doi: 10.1007/s00109-017-1528-2. Epub 2017 Apr 2.

Synovial cell production of IL-26 induces bone mineralization in spondyloarthritis.

Author information

1
Department of Biomedicine, Aarhus University, Wilhelm Meyers Allé 4, 8000, Aarhus C, Denmark.
2
Department of Rheumatology, Aarhus University Hospital, Nørrebrogade 44, 8000, Aarhus C, Denmark.
3
Department of Immunology and Microbiology, University of Copenhagen, Blegdamsvej 3c, 2200, Copenhagen N, Denmark.
4
Department of Rheumatology, Regional Hospital Silkeborg, Falkevej 1-3, 8600, Silkeborg, Denmark.
5
Department of Gastroenterology, Infectiology, and Rheumatology, Charité Universitätsmedizin Berlin, 12200, Berlin, Germany.
6
Department of Clinical Medicine, Aarhus University, Palle Juul-Jensens Boulevard 82, 8200, Aarhus N, Denmark.
7
Department of Biomedicine, Aarhus University, Wilhelm Meyers Allé 4, 8000, Aarhus C, Denmark. bd@biomed.au.dk.
8
Department of Rheumatology, Aarhus University Hospital, Nørrebrogade 44, 8000, Aarhus C, Denmark. bd@biomed.au.dk.
9
Department of Clinical Medicine, Aarhus University, Palle Juul-Jensens Boulevard 82, 8200, Aarhus N, Denmark. bd@biomed.au.dk.

Abstract

Spondyloarthritis (SpA) is characterized by inflammation and new bone formation and can be treated by inhibition of the proinflammatory cytokines TNF-α and IL-17A. IL-26 is considered a proinflammatory cytokine, predominantly related to Th17 cells. In the present study, we investigate IL-26 expression in SpA patients, and examine the in vitro production of IL-26 by synovial cells and the effects of IL-26 on human osteoblasts. IL-26 was measured by ELISA in plasma and synovial fluid (SF) of 15 SpA patients and in plasma samples from 12 healthy controls. Facet joints from axial SpA patients were stained for IL-26 and analyzed by fluorescence microscopy. Synovial fluid mononuclear cells, C-C motif chemokine receptor 6 memory Th17 cells, and fibroblast-like synoviocytes (FLSs) were isolated, and supernatants were analyzed for IL-26 content by ELISA. FLSs were further stained for IL-26 production and the myofibroblast marker α-smooth-muscle-actin (αSMA) and analyzed by flow cytometry. Human osteoblasts were cultured in the presence of IL-26, and the degree of mineralization was quantified. We found that IL-26 levels in SF were increased compared with plasma (P < 0.0001). Moreover, IL-26 expression was found in facet joints of axial SpA patients within the bone marrow. IL-26 secretion was primarily found in αSMA+ myofibroblasts. In contrast, Th17 cells did not produce detectable amounts of IL-26. Human osteoblasts treated with IL-26 showed increased mineralization compared with untreated osteoblasts (P = 0.02). In conclusion, IL-26 seems to be produced by myofibroblasts in the inflamed synovium and could be a possible facilitator of bone mineralization in SpA.

KEY MESSAGES:

IL-26 levels are higher in synovial fluid compared to plasma in spondyloarthritis. IL-26 was identified in axial facet joints of spondyloarthritis patients. Myofibroblasts from the spondyloarthritis synovium produce large amounts of IL-26. IL-26 induces bone mineralization in human osteoblasts.

KEYWORDS:

Fibroblasts; IL-26; Osteoblasts; Spondyloarthritis; TNF-α

PMID:
28365787
DOI:
10.1007/s00109-017-1528-2
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center